Advertisement
Advertisement
ASTH
Astrana Health Inc. Common Stock
34.48
USDSponsored
-2.99
-7.98%
Aug 11, 16:00 UTC -4
Closed
After-Market
34.59
+0.11
+0.30%
ASTH Earnings Reports
Positive Surprise Ratio
ASTH beat 20 of 33 last estimates.
61%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.05B
/$0.41
Implied change from Q2 26 (Revenue/ EPS)
+7.59%
/+2.50%
Implied change from Q3 25 (Revenue/ EPS)
+9.44%
/+4000.00%
Astrana Health Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, ASTH reported earnings of 0.40 USD per share (EPS) for Q2 26, beating the estimate of 0.34 USD, resulting in a 16.72% surprise. Revenue reached 972.52 million, compared to an expected 1.01 billion, with a -3.27% difference. The market reacted with a +4.78% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of 0.41 USD, with revenue projected to reach 1.05 billion USD, implying an increase of 2.50% EPS, and increase of 7.59% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
The Pennant Group, Inc. Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.33
Actual
$0.36
Surprise
+6.95%
US Physical Therapy Inc
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.86
Actual
$0.75
Surprise
-12.81%
Encompass Health Corporation Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$1.49
Actual
$1.55
Surprise
+3.72%
DaVita Inc.
Report Date
Aug 04, 2026 For Q2 26
Estimate
$3.92
Actual
$4.01
Surprise
+2.52%
Elanco Animal Health Incorporated Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.27
Actual
$0.34
Surprise
+23.77%
LifeStance Health Group, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.04
Actual
$0.06
Surprise
+34.53%
Option Care Health, Inc. Common Stock
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.43
Actual
$0.45
Surprise
+3.16%
Addus HomeCare Corp.
Report Date
Aug 03, 2026 For Q2 26
Estimate
$1.73
Actual
$1.73
Surprise
-0.18%
FAQ
What were Astrana Health Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Astrana Health Inc. Common Stock reported EPS of $0.40, beating estimates by 16.72%, and revenue of $972.52M, -3.27% below expectations.
How did the market react to Astrana Health Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 4.78%, changed from $34.13 before the earnings release to $35.76 the day after.
When is Astrana Health Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Astrana Health Inc. Common Stock's next earnings report?
Based on 9
analysts, Astrana Health Inc. Common Stock is expected to report EPS of $0.41 and revenue of $1.05B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement